ArticleFrontiers in oncology2022

B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma.

Jhe-Cyuan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.